ABSTRACT
Estrogen deficiency plays a major role in the pathogenesis of bone loss and contributes to the impairment of quality of life in a large number of postmenopausal women. On the other hand, the positive effect of hormone therapy (HT) on bone density and fractures is well established, as is the beneficial action of HT on several aspects of wellbeing throughout the menopause and beyond1,2.
